Neuro-Oncology Reviews
Volume
26 Number 27
30 November 2024
Home > Publications > Neuro-Oncology Reviews > Volume 26, Year 2024 > Number 27, 30 November
Badani A, Ozair A, Khasraw M, Woodworth GF, Tiwari P, Ahluwalia
MS, Mansouri A.
Immune checkpoint
inhibitors for glioblastoma: emerging science, clinical advances,
and future directions.
J
Neurooncol. 2024 Nov 21. doi:
10.1007/s11060-024-04881-2. PMID:
39570554. Review˰ ˍ
Hansford JR, Manoharan N, Bouche G, Ramaswamy V, Jabado N, Bouffet
E.
ONC201 (Dordaviprone): review of
evidence to date in diffuse midline glioma, hope or hype?
Expert
Opin Emerg Drugs. 2024 Nov 21:1-5. doi:
10.1080/14728214.2024.2426649. PMID:
39548664. Perspective. ˍ
Percuoco V, Herlin E, Prada F, Riva M, Pessina F, Staartjes VE,
Della Pepa GM, Menna G.
Glioblastoma
invasion patterns from a clinical perspective-a systematic review.
Neurosurg
Rev. 2024 Nov 21;47(1):864. doi:
10.1007/s10143-024-02944-6. PMID:
39570467. Review. ˍ
Zeng L, Yang H, Li H, Chen R, Chen J, Yu J.
Risk
factors for and molecular pathology characteristics of systemic
metastasis of adult cerebral glioblastoma: A pooled individual
patient data analysis and systematic review.
J
Neurol Surg A Cent Eur Neurosurg. 2024 Nov 21. doi:
10.1055/a-2479-9978. PMID:
39572244. Review˰ ˍ
Cómitre-Mariano B, Vellila-Alonso G, Segura-Collar B,
Mondéjar-Ruescas L, Sepulveda JM, Gargini R.
Sentinels
of neuroinflammation: the crucial role of myeloid cells in the
pathogenesis of gliomas and neurodegenerative diseases.
J
Neuroinflammation. 2024 Nov 22;21(1):304. doi:
10.1186/s12974-024-03298-y. PMID:
39578808. Review. ˍ
Sahm F, Bertero L, Brandner S, Capper D, Goldbrunner R, Jenkinson
MD, Kalamarides M, Lamszus K, Albert NL, Mair MJ, Berghoff AS,
Mawrin C, Wirsching HG, Maas SL, Raleigh DR, Reifenberger G,
Schweizer L, Suwala AK, Tabatabai G, Tabouret E, Short S, Wen PY,
Weller M, Le Rhun E, Wesseling P, van den Bent M, Preusser M.
EANO guideline on molecular testing of
meningiomas for targeted therapy selection.
Neuro
Oncol. 2024 Nov 22:noae253. doi:
10.1093/neuonc/noae253. PMID:
39577862. Guidelines. ˍ
Ismail FS, Gallus M, Meuth SG, Okada H, Hartung HP, Melzer N.
Current and Future Roles of Chimeric
Antigen Receptor T-Cell Therapy in Neurology: A Review.
JAMA
Neurol. 2024 Nov 25. doi:
10.1001/jamaneurol.2024.3818. PMID:
39585688. Review˰ ˍ
Prakash V, Gabrani R.
Epigenetic
dysregulation in glioblastoma: potential pathways to precision
medicine.
Neurogenetics.
2024 Nov 25;26(1):5. doi:
10.1007/s10048-024-00793-5. PMID:
39585441. Review˰ ˍ
Salomoni P.
Understanding brain cancer
and exploiting its vulnerabilities.
Mol
Oncol. 2024 Nov 25. doi:
10.1002/1878-0261.13769. PMID:
39582358. Editorial. ˍ
Soukup J, Hajkova N, Hajkova V, Svajdler M, Netuka D, Majovsky M.
A glioneuronal tumor with neurocytic
rosettes harboring FGFR1 internal tandem duplication - A report of
a unique case.
Neuropathology.
2024 Nov 25. doi:
10.1111/neup.13018. PMID:
39586795. Case report; Review˰
ˍ
Sharma S, Gone GB, Roychowdhury P, Kim HS, Chung SJ, Kuppusamy G,
De A.
Photodynamic and sonodynamic
therapy synergy: mechanistic insights and cellular responses
against glioblastoma multiforme.
J
Drug Target. 2024 Nov 26:1-15. doi:
10.1080/1061186X.2024.2431676. PMID:
39556529. Review˰ ˍ
Bou-Gharios J, Noël G, Burckel H.
The
neglected burden of chronic hypoxia on
the resistance of glioblastoma
multiforme to first-line therapies.
BMC
Biol. 2024 Nov 28;22(1):278. doi:
10.1186/s12915-024-02075-w. PMID:
39609830. Review. ˍ
Hajikarimloo B, Habibi MA, Kooshki A, Alvani MS, Zare AH,
Hasanzade A, Zare AH, Akhlaghpasand M, Tavanaei R, Tos
SM.
Dabrafenib plus trametinib in
low-grade versus
high-grade gliomas: a systematic review and meta-analysis.
BMC
Cancer. 2024 Nov 29;24(1):1473. doi:
10.1186/s12885-024-13229-y. PMID:
39614165. Review; Meta-analysis. ˍ
Swensen SN, Figuracion KCF, Venur VA, Emerson S, Tseng YD, Lo SS,
Ermoian RP, Halasz LM.
Treatment
Options for IDH-Mutant Malignant Gliomas.
Curr
Treat Options
Oncol. 2024 Nov 29. doi:
10.1007/s11864-024-01280-7. PMID:
39612163. Review˰ ˍ
De Vleeschouwer S, editor.
Glioblastoma.
Codon
Publications. 2017 Sep 27. Book. ˍ
Debinski W, editor.
Gliomas.
Exon
Publications. 2021 Apr 30. Book. ˍ
Werner JM, Petrescu GED, Boele F, Preusser M, Platten M, Chalmers
AJ, Short SC, Piil K.
Chairing
scientific sessions at international neuro-oncology meetings: An
EANO guide for early-career professionals.
Neurooncol
Pract. 2024 Jul 2;11(6):673-676. doi:
10.1093/nop/npae060. PMID:
39554779. Guidelines˰ ˍ
Ekert JO, Goyal A, Young JS, Hervey-Jumper SL, Berger MS.
Interventional neurorehabilitation for
glioma patients: A systematic review.
Neurooncol
Pract. 2024 Jul 16;11(6):679-690. doi:
10.1093/nop/npae066. PMID:
39554784. Review˰ ˍ
Javed Z, Sadiq R, Shamim MS.
Management
of high grade primary cerebellar tumours.
J
Pak Med Assoc. 2024 Oct 16;74(11):2018-2020. doi:
10.47391/JPMA.24-92. PMID:
39548629. Review. ˍ
Trevisi G, Mangiola A.
Editorial for
Special Issue "Brain Tumor Microenvironment".
Cancers
(Basel). 2024 Nov 18;16(22):3864. doi:
10.3390/cancers16223864. PMID:
39594818. Editorial. ˍ
van Opijnen MP, Sadigh Y, Dijkstra ME, Young JS, Krieg SM, Ille S,
Sanai N, Rincon-Torroella J, Maruyama T, Schucht P, Smith TR,
Nahed BV, Broekman MLD, De Vleeschouwer S, Berger MS, Vincent
AJPE, Gerritsen JKW.
The impact of
intraoperative mapping during re-resection in recurrent gliomas: a
systematic review.
J
Neurooncol. 2024 Nov 18. doi:
10.1007/s11060-024-04874-1. PMID:
39556284. Review. ˍ
Abo-Elnour DE, Pichardo-Rojas PS, Abdalla YE, Salama MK, Elboraay
T, Rizk MA, Negida A, Raslan AM.
Comparative
efficacy of awake and asleep motor mapping in glioma surgery: A
meta-analysis of 3011 patients.
Neurosurg
Rev. 2024 Nov 19;47(1):859. doi:
10.1007/s10143-024-03080-x. PMID:
39560794. Meta-analysis˰
ˍ
Zou S, Chen Q, Shen Z, Qin B, Zhu X, Lan Y.
Update
on the roles of regular daily rhythms in combating brain tumors.
Eur
J Pharmacol. 2024 Nov 19;986:177144. doi:
10.1016/j.ejphar.2024.177144. PMID:
39571672. Review˰ ˍ
Zafar Sheikh A.
Unveiling the Enigma:
Multiple Primary Neoplasms Mimicking Metastatic Disease.
Cureus.
2024 Oct 22;16(10):e72145. doi:
10.7759/cureus.72145. PMID:
39575008. Case report; Review. ˍ
Bagheri-Mohammadi S, Karamivandishi A, Mahdavi SA,
Siahposht-Khachaki A.
New sights on
long non-coding RNAs in glioblastoma: A review of molecular
mechanism.
Heliyon. 2024 Oct 23;10(21):e39744. doi:
10.1016/j.heliyon.2024.e39744. PMID:
39553554. Review. ˍ
Green GBH, Cox-Holmes AN, Potier ACE, Marlow GH, McFarland BC.
Modulation of
the Immune Environment in
Glioblastoma by the Gut Microbiota.
Biomedicines.
2024 Oct 23;12(11):2429. doi:
10.3390/biomedicines12112429. PMID:
39594997. Review. ˍ
Ishaque AH, Das S.
Cutting Through
History: The Evolution of Glioblastoma
Surgery.
Curr
Oncol. 2024 Oct 24;31(11):6568-6576. doi:
10.3390/curroncol31110485. PMID:
39590116. Review. ˍ
Ge Y, Cao Y, Wang Q, Wang Y, Ma W.
Impact
of antidepressant use on survival outcomes in glioma patients: A
systematic review and meta-analysis.
Neurooncol
Adv. 2024 Oct 26;6(1):vdae181. doi:
10.1093/noajnl/vdae181. PMID:
39582812. Review; Meta-analysis. ˍ
Agosti E, Antonietti S, Ius T, Fontanella MM, Zeppieri M, Panciani
PP.
A
Systematic Review of Mesenchymal Stem
Cell-Derived Extracellular Vesicles: A
Potential Treatment for Glioblastoma.
Brain
Sci. 2024 Oct 25;14(11):1058. doi:
10.3390/brainsci14111058. PMID:
39595821. Review. ˍ
Choate KA, Pratt EPS, Jennings MJ, Winn RJ, Mann PB.
IDH
Mutations in Glioma: Molecular,
Cellular, Diagnostic, and Clinical Implications.
Biology
(Basel). 2024 Oct 30;13(11):885. doi:
10.3390/biology13110885. PMID:
39596840. Review. ˍ
Wu H, Gao W, Chen P, Wei Y, Zhao H, Wang F.
Research
progress of drug resistance mechanism of temozolomide in the
treatment of glioblastoma.
Heliyon.
2024 Oct 30;10(21):e39984. doi:
10.1016/j.heliyon.2024.e39984. PMID:
39568843. Review. ˍ
Torregrossa F, Grasso G.
Atypical
Meningioma: State of Art and Future
Perspectives.
J
Integr Neurosci. 2024 Oct 31;23(11):199. doi:
10.31083/j.jin2311199. PMID:
39613461. Editorial. ˍ
Liu J, Peng J, Jiang J, Liu Y.
Clinical
immunotherapy in glioma: current concepts, challenges, and future
perspectives.
Front
Immunol. 2024 Nov 1;15:1476436. doi:
10.3389/fimmu.2024.1476436. PMID:
39555054. Review. ˍ
Meléndez-Vázquez NM, Gomez-Manzano C, Godoy-Vitorino
F.
Oncolytic
Virotherapies and Adjuvant Gut
Microbiome Therapeutics to Enhance Efficacy
Against Malignant Gliomas.
Viruses.
2024 Nov 14;16(11):1775. doi:
10.3390/v16111775. PMID:
39599889. Review. ˍ
Spallotta F, Illi B.
The Role of HDAC6
in Glioblastoma Multiforme: A New
Avenue to Therapeutic Interventions?
Biomedicines.
2024 Nov 17;12(11):2631. doi:
10.3390/biomedicines12112631. PMID:
39595195. Review. ˍ
Valerio J, Borro M, Santiago Rea N, Valente L, Fernandez-Gomez MP,
Zumaeta J, Mantilla P, Alvarez-Pinzon AM.
Radiosurgery
for Hypothalamic Gliomas: A Case Report and Clinical Guidelines
Form a Neurosurgical Center of Excellence.
J
Pers Med. 2024 Nov 15;14(11):1108. doi:
10.3390/jpm14111108. PMID:
39590600. Case report; Guidelines. ˍ
Alirezaei Z, Amouheidari A, BasirianJahromi R, Seyyedhosseini S,
Hamidi A.
Survival Analysis of
Glioblastoma: A Scientometric Perspective.
World
Neurosurg. 2024 Nov 20:S1878-8750(24)01919-3? doi:
10.1016/j.wneu.2024.11.059? PMID:
39577630. Bibliometric analysis˰
ˍ
Beutler BD, Fan Z, Lerner A, Cua R, Zheng S, Rajagopalan P, Phung
DC, Shiroishi MS, Sheikh-Bahaei N, Antwi-Amoabeng D, Assadsangabi
R.
Pearls and Pitfalls of T1-Weighted
Neuroimaging: A Primer for the Clinical Radiologist.
Acad
Radiol. 2024 Nov 20:S1076-6332(24)00835-3. doi:
10.1016/j.acra.2024.10.048. PMID:
39572296. Education˰ ˍ
Wireko AA, Ben-Jaafar A, Kong JSH, Mannan KM, Sanker V, Rosenke
SL, Boye ANA, Nkrumah-Boateng PA, Poornaselvan J, Shah MH,
Abdul-Rahman T, Atallah O.
Sonic
hedgehog signalling pathway in CNS tumours: its role and
therapeutic implications.
Mol
Brain. 2024 Nov 20;17(1):83. doi:
10.1186/s13041-024-01155-w. PMID:
39568072. Review. ˍ
Ziu M, Halasz LM, Kumthekar PU, McGranahan TM, Lo SS, Olson JJ.
Congress of Neurological Surgeons
systematic review and evidence-based guidelines for the role of
chemotherapy in newly diagnosed WHO Grade II diffuse glioma in
adults: update.
J
Neurooncol. 2024 Nov 20. doi:
10.1007/s11060-024-04861-6. PMID:
39565459. Review; Guidelines˰
ˍ